Possibilities
TECVAYLI® is a prescription medicine to treat adults with multiple myeloma who:
TECVAYLI® was approved based on patient responses. There are ongoing studies to confirm the clinical benefit of TECVAYLI®.
It is not known if TECVAYLI® is safe and effective in children.
TECVAYLI® is the first treatment of its kind for multiple myeloma—it’s called a , and it works by binding to both multiple myeloma cells as well as to help your recognize the multiple myeloma cells and destroy them.
TECVAYLI® was studied in 110 heavily pretreated people:
62%Responded to
TECVAYLI®
All patients had previously received a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody:
Talk your doctor for more information about response.
RESPONSE WITH TECVAYLI® 62% of people in the clinical trial who took TECVAYLI® responded.
SUBCUTANEOUS INJECTION TECVAYLI® is given by a doctor or nurse as a subcutaneous injection under the skin, usually in your stomach area (abdomen), your thigh, or another area of your body.
WORKS DIFFERENTLY TECVAYLI® works by binding to both multiple myeloma cells as well as T-cells to help your immune system recognize the multiple myeloma cells and destroy them.
If your multiple myeloma is refractory or relapsed, ask your healthcare provider if TECVAYLI® is right for you.
MEET MIKE
Hear Mike's Story
I have the greatest support staff—my amazing wife, my children, my parents, my family.
Mike is a real patient who’s been living with multiple myeloma for over 8 years. Listen as he and his wife discuss his journey from diagnosis through relapse, as well as their relationship as both husband and wife and patient and care partner.
Mike received TECVAYLI®
When you have multiple myeloma, the medicines that were working before can stop working, and you can experience relapse. When you try a medicine but don’t get a , this means your multiple myeloma is refractory to that medicine.
There are still ways to fight , including trying a different medicine from the kinds you have already tried.
If your multiple myeloma is refractory or relapsed, ask your healthcare provider if TECVAYLI® is right for youTECVAYLI® is for adults with multiple myeloma whose cancer has come back or did not respond to treatment after having received at least 4 prior , including:
a proteasome inhibitoran immunomodulatory agentan anti-CD38 monoclonal antibodyTECVAYLI® was approved based on patient responses. There are ongoing studies to confirm the clinical benefit of TECVAYLI®. It is not known if TECVAYLI® is safe and effective in children.
If you’re going through another relapse, it may be time to talk to your doctor about making a change
There are medicines for relapsed or refractory multiple myeloma that may be able to help manage your disease. Talk to your doctor to see if TECVAYLI® is right for you.
Here are some questions that can help start that conversation
Once you and your doctor have decided that TECVAYLI® is right for you, sign up for TECVAYLI withMe
TECVAYLI withMe: Personalized 1-on-1 Support
You have access to free, dedicated support. Your Care Navigator is here to help guide you to support solutions throughout your treatment journey, so you feel informed and empowered.
Starting a new treatment can be overwhelming and you may still have questions. We are here to help.
Free 1-on-1 Dedicated Care Navigator Support
Cost Support Options Regardless of Your Insurance Type
Additional Resources and Community Connections
Sign-up for personalized support throughout your treatment journey now
OR
Call 833-JNJ-wMe1 (833-565-9631), Monday through Friday, 8:00 AM–8:00 PM ET.
The support and resources provided by TECVAYLI withMe are not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.